Hazardous Drugs

NIOSH Hazardous Drugs

Repackaged by Safecor Health and compliant with USP <800>

The National Institute for Occupational Safety and Health (NIOSH) considers a drug to be hazardous if it exhibits at least one of the following criteria: carcinogenicity, teratogencicity or developmental toxicity, reproductive toxicity, organ toxicity at low doses, genotoxicity, or structure and toxicity profiles of new drugs that mimic existing hazardous drugs.

Safecor Health will repackage the following drugs defined as hazardous on the NIOSH list.

Table 1:
Antineoplastics

 

Table 2:
Non-Antineoplastic

(one or more criteria)

Table 3:
Non-Antineoplastic

(reproductive effects)

abiraterone abacavir acitretin
anastrozole carbamazepine ambrisentan
bicalutamide contraceptives bosentan
enzalutamide cyclosporine cabergoline
erlotinib deferiprone clonazepam
exemestane divalproex colchicine
flutamide entecavir dronedarone
letrozole estrogen dutasteride
megestrol fluoxymesterone ergonovine
tamoxifen leflunomide eslicarbazepine
medroxyprogesterone acetate finasteride
methimazole fluconazole
mycophenolate methylergonovine
nevirapine methyltestosterone
oxcarbazepine misoprostol*
phenoxybenzamine paroxetine
phenytoin ribavirin
progesterin temazepam
propylthiouracil testosterone
raloxifene topiramate
rasagiline valproate/valproic acid
sirolimus voriconazole
spironolactone warfarin
tacrolimus ziprasidone
teriflunomide zoledronic acid
valganciclovir zonisamide
zidovudine

*Full tabs only. Cannot repackage half or quarter tabs.

 

Contact us for more information on our packaging capabilities.